Blog

  • Recent Match Report – West Indies vs Australia, Australia tour of West Indies, 3rd Test

    Recent Match Report – West Indies vs Australia, Australia tour of West Indies, 3rd Test

    Australia 225 and 99 for 6 (Green 42*, Alzarri 3-19, Shamar 2-26) lead West Indies 143 (Boland 3-34, Cummins 2-24, Hazlewood 2-32) by 181 runs

    West Indies’ pace bowlers surged under lights on the second day at Sabina Park as the Test moved a breakneck speed with Australia stumbling to 99 for 6 amid a torrid working over in some of the toughest conditions imaginable.

    Sam Konstas’ miserable series ended with a duck, leaving his Test prospects for the Ashes in jeopardy, but Cameron Green played outstandingly for an innings worth far more than the 42 on the scoreboard although he could have been run out on 14. By the close of another hectic day which saw 15 wickets fall, Australia held a lead of 181 which was already considerable in the conditions but West Indies had given themselves a glimmer.

    West Indies had been dismantled for 143 with Australia’s bowling sharing the success. Scott Boland, who replaced Nathan Lyon in the XI, finished with three wickets. It meant a first-innings lead of 82 for Australia, but also saw them starting their second innings at the beginning of the final session as the lights took full hold.

    The passage of play when West Indies took the new ball was electrifying. Konstas wasn’t able to get off the mark as he jabbed at a short-of-a-length delivery from Shamar Joseph and was taken in the gully. It left Konstas, who had been billed as the future of the top order, with 50 runs in the series at 8.33.

    Usman Khawaja managed to take his balls-faced tally in the series to over 300 – a not inconsiderable achievement given the conditions – but inside-edged a big drive against Shamar Joseph into his stumps, making it all six dismissals for the series from around the wicket.

    Then Alzarri Joseph turned up the throttle against Steven Smith with a spell where he touched 147kph and produced the fastest over by a West Indies bowler in the series.

    Smith was dropped on 1, a low chance to Justin Greaves at second slip, and appeared to have trouble sighting the ball which is a challenge he has spoken about in day-night Tests. With his 12th delivery to him, Alzarri found the inside edge with a fuller delivery having pinned Smith back in the crease.

    West Indies spurned a golden chance to remove Green when he and Travis Head were caught ball-watching over a single. Briefly the pair resisted, but it couldn’t last as Head sent a low catch to second slip against Greaves.

    Beau Webster was defeated by late movement from Alzarri, a virtually unplayable delivery, and Alex Carey edged a wild drive to slip two balls after being clanged on the helmet by a bouncer that required repair work to the helmet. Carey’s stroke was one of a batter not backing their chances of hanging around.

    As with the opening day, the game moved at a much more sedate pace for the first two hours. West Indies had fought hard during the morning session which took on a similar pattern to Australia’s first innings where the scoring rate was low. They were 73 for 3 at the interval and later 124 for 5 before tumbling in a heap with a mixture of good deliveries and poor batting.

    Brandon King, who had opened after injuries to John Campbell and Mikyle Louis on the first day, had been solid during the opening exchanges before falling to a bail-trimming lbw against Josh Hazlewood.

    There was a brief moment of controversy when John Campbell was nearly run out by Pat Cummins’ under-arm flick from mid-on. Nitin Menon didn’t call for the TV umpire and said Australia hadn’t appealed. Replays showed Campbell’s bat bounced but had been ground fractionally over the line beforehand. There was a heated conversation between Cummins and Menon in the aftermath.

    Roston Chase had battled through 70 balls when he edged a lifter from Cummins to first slip as he tried to drop the bat and gloves out of the line.

    Campbell, meanwhile, had shaped up well, showing good judgement with tip and runs while latching onto anything slightly lose, especially a crunching cover drive against Hazlewood. However, a moment of misjudgment ended his stay when he shouldered arms to Boland.

    Louis, who hurt his knee on the opening day, played the worst shot from the top order, a horrid swipe across the line to leave West Indies 95 for 5.

    But Australia weren’t blemish free. Carey missed two chances, the first when he dived across in front of first slip for an edge off Greaves then a low inside edge from Shai Hope. However, Hope fell next ball when a delivery nipped sharply from Boland, scooting past the inside edge.

    From there the innings subsided which included Greaves being run out coming back for a third when he was beaten by Konstas’ excellent throw from the deep.


    Continue Reading

  • Recent Match Report – West Indies vs Australia, Australia tour of West Indies, 3rd Test

    Recent Match Report – West Indies vs Australia, Australia tour of West Indies, 3rd Test

    Australia 225 and 99 for 6 (Green 42*, Alzarri 3-19, Shamar 2-26) lead West Indies 143 (Boland 3-34) by 181 runs

    West Indies’ pace bowlers surged under lights on the second day at Sabina Park as the Test moved a breakneck speed with Australia stumbling to 99 for 6 amid a torrid working over in some of the toughest conditions imaginable.

    Sam Konstas’ miserable series ended with a duck, leaving his Test prospects for the Ashes in jeopardy, but Cameron Green played outstandingly for an innings worth far more than the 42 on the scoreboard although he could have been run out on 14. By the close of another hectic day which saw 15 wickets fall, Australia held a lead of 181 which was already considerable in the conditions but West Indies had given themselves a glimmer.

    West Indies had been dismantled for 143 with Australia’s bowling sharing the success. Scott Boland, who replaced Nathan Lyon in the XI, finished with three wickets. It meant a first-innings lead of 82 for Australia, but also saw them starting their second innings at the beginning of the final session as the lights took full hold.

    The passage of play when West Indies took the new ball was electrifying. Konstas wasn’t able to get off the mark as he jabbed at a short-of-a-length delivery from Shamar Joseph and was taken in the gully. It left Konstas, who had been billed as the future of the top order, with 50 runs in the series at 8.33.

    Usman Khawaja managed to take his balls-faced tally in the series to over 300 – a not inconsiderable achievement given the conditions – but inside-edged a big drive against Shamar Joseph into his stumps, making it all six dismissals for the series from around the wicket.

    Then Alzarri Joseph turned up the throttle against Steven Smith with a spell where he touched 147kph and produced the fastest over by a West Indies bowler in the series.

    More to follow

    Continue Reading

  • New guideline recommends proper preconception care for women with diabetes

    New guideline recommends proper preconception care for women with diabetes

    A joint guideline released today from the Endocrine Society and the European Society of Endocrinology (ESE) recommends women with diabetes receive proper preconception care and access to emerging diabetes technology and therapeutics to manage their blood sugar before, during and after pregnancy.

    Adverse pregnancy outcomes such as miscarriages or birth defects are common in individuals with pre-existing diabetes and are often related to modifiable factors such as maternal high blood sugar and body mass index (BMI).

    Screening women of reproductive age who have diabetes for intent to conceive at every reproductive, diabetes and primary care visit helps ensure they get the appropriate preconception care and reduces health risks.

    “Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline,” was published online in the Society’s respective journals, The Journal of Clinical Endocrinology & Metabolism (JCEM) and the European Journal of Endocrinology (EJE), and is being presented today at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.

    We developed these guidelines as diabetes rates are rising among women of reproductive age and very few women with diabetes receive proper preconception care. In addition to preconception planning, the guideline discusses advances in diabetes technology, delivery timing, medications and diet.”


    Guideline Chair Jennifer Wyckoff, M.D., of the University of Michigan in Ann Arbor, Mich.

    Summary of suggestions from the guideline include: 

    • Screening-ask all women with diabetes of reproductive age about intent to conceive at every reproductive, diabetes and primary care visit.



    • Delivery timing-before 39 weeks for pregnant individuals with diabetes as the risks associated with continued pregnancy may outweigh those of early delivery

    • Medications-discontinue anti-obesity medications called GLP-1s prior to pregnancy; avoid prescribing metformin in pregnant individuals with preexisting diabetes already on insulin

    • Diabetes technology-recommend hybrid closed loop systems for pregnant individuals with type 1 diabetes

    • Contraception-suggest women with diabetes use contraception until they are ready to become pregnant 

     

    “The guidelines highlight the need for research and investment into preconception care, more randomized control trials to define glycemic targets in pregnancy, and data on optimal nutrition and obesity management in pregnancy,” Wyckoff said.

    Guideline Co-chair Annunziata Lapolla, M.D., of the University of Padova in Padova, Italy commented, “During the preparation of these guidelines, the panel prioritized randomized controlled trials (RCTs), and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology was used to assess the certainty of evidence and guide recommendations.”

    She continued, “Given the increase in type 2 diabetes associated with obesity worldwide and women with this pathology who become pregnant, these recommendations have also addressed the issues related to correct nutrition and therapeutic approach in such women.”

    Other members of the writing committee that developed this guideline include: Bernadette D. Asias-Dinh of the University of Houston in Houston, Texas; Linda A. Barbour of the University of Colorado School of Medicine and Anschutz Medical Campus in Aurora, Colo.; Florence M. Brown of Joslin Diabetes Center in Boston, Mass.; Patrick M. Catalano of Massachusetts General Hospital and Harvard Medical School in Boston, Mass.; Rosa Corcoy of Hospital de la Santa Creu i Sant Pau in Barcelona, Spain, CIBER-BBN in Madrid, Spain, and Universitat Autònoma de Barcelona in Barcelona, Spain; Gian Carlo Di Renzo of PREIS International School and Meyer Children’s University Hospital in Florence, Italy; Nancy Drobycki of the University of Texas Southwestern Medical Center of Dallas in Dallas, Texas; Alexandra Kautzky-Willer of the Medical University of Vienna in Vienna, Austria; M. Hassan Murad of the Mayo Clinic Evidence-Based Practice Center in Rochester, Minn.; Melanie Stephenson-Gray of National Health Service in Cardiff, United Kingdom; Adam G. Tabák of Semmelweis University of Medicine in Budapest, Hungary, and the University College London in London, United Kingdom; Emily Weatherup of the University of Michigan in Ann Arbor, Mich.; Chloe Zera of the Beth Israel Deaconess Medical Center in Boston, Mass.; and Naykky Singh-Ospina of the University of Florida in Gainesville, Fla.

    The Clinical Practice Guideline Program provides endocrinologists and other clinicians with evidence-based recommendations in the diagnosis, treatment and management of endocrine-related conditions. Each guideline is developed by a multidisciplinary panel of topic-related experts in the field using a rigorous methodology.

    Guideline writing panels rely on evidence-based reviews of the literature when developing guideline recommendations. Neither the Endocrine Society nor ESE solicit or accept corporate support for guidelines. All Clinical Practice Guidelines are supported entirely by Society funds.

    This Clinical Practice Guideline was co-sponsored by the American Diabetes Association, the American College of Obstetricians and Gynecologists, the Society for Maternal-Fetal Medicine, The International Association of the Diabetes and Pregnancy Study Groups, the European Association for the Study of Diabetes, the Association of Diabetes Care and Education Specialists, and the American Pharmacists Association.

    Continue Reading

  • U.S. stock futures slip after Trump’s latest tariff threats; bitcoin hits new high

    U.S. stock futures slip after Trump’s latest tariff threats; bitcoin hits new high

    By Mike Murphy

    U.S. stock futures fell Sunday, a day after President Donald Trump threatened to impose new 30% tariffs against imports from Mexico and the European Union.

    Dow Jones Industrial Average futures (YM00) dropped about 180 points, or 0.4%, as of 10:15 p.m. Eastern on Sunday. S&P 500 futures (ES00) and Nasdaq-100 futures (NQ00) also dipped about 0.4%. Front-month West Texas Intermediate crude prices (CL.1) inched higher, as did the price of gold (GC00). The ICE U.S. Dollar Index DXY, a gauge of the greenback against six major peers, gained slightly.

    Earlier Sunday, bitcoin (BTCUSD) hit a new record high at $119,487. Last week, bitcoin topped the $111,000 level for the first time, and Katie Stockton, founder and managing partner at Fairlead Strategies, said bitcoin could ride its current momentum to around $134,500 after its latest technical breakout. Bitcoin has rallied about 10% over the past week, and has gained about 27% year to date.

    On Saturday, Trump threatened new 30% tariffs on goods from the European Union and Mexico, effective Aug. 1. That came after the Trump administration last week announced a 35% tariff on Canadian goods, and tariffs of 25% on imports from Japan and South Korea, also effective Aug. 1.

    On Sunday, the E.U. said it will delay retaliatory tariffs against U.S. goods, set to take effect Monday, in order to give more time to reach a trade deal by Aug. 1.

    “This is now the time for negotiations,” European Commission President Ursula von der Leyen said Sunday in Brussels, according to the Associated Press, after warning Saturday that “imposing 30% tariffs on E.U. exports would disrupt essential transatlantic supply chains, to the detriment of businesses, consumers and patients on both sides of the Atlantic.”

    Financial markets have largely taken Trump’s tariff threats in stride in recent months, as they’ve been repeatedly postponed, giving rise to the so-called TACO – “Trump always chickens out” – trade.

    Monday’s trading will likely put the TACO theory to the test. “Markets have priced it all mainly as noise, but there’s a growing sense that this time may be different,” Stephen Innes, managing partner at SPI Asset Management, said in a note Sunday night. “The 30% number is not just headline bait; it’s punitive by design, and the street will grow increasingly jittery as the tariff deadline clock ticks down.”

    While markets have been adapting to Trump’s tariff ambiguity, “this balancing act is getting riskier by the week,” Innes said.

    Stocks ended lower Friday amid the tariff worries. The Dow Jones Industrial Average DJIA lost 1% for the week, snapping a three-week winning streak. The S&P 500 SPX broke a two-week winning streak, declining 0.3%, while the Nasdaq Composite COMP slipped about 0.1% on the week.

    Meanwhile, the 30-year Treasury yield made its biggest weekly rise since May, on growing fears of inflation driven by Trump’s tariff wars. Tuesday’s consumer-price index report for June should shed more light on the state of inflation, and may test the will of investors, who have largely hung tight despite Trump’s tariff threats.

    Read more: Stocks and U.S. government bonds sell off in tandem Friday as trade jitters cool rally

    Investors will also be looking at second-quarter earnings from companies including JPMorgan Chase & Co. (JPM) and Netflix Inc. (NFLX), in what should be the first full-quarter test of the impact of Trump’s tariffs on corporate earnings. Wall Street analysts expect companies to report the lowest level of quarterly growth per share since the end of 2023, according to FactSet.

    -Mike Murphy

    This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

    (END) Dow Jones Newswires

    07-13-25 2224ET

    Copyright (c) 2025 Dow Jones & Company, Inc.

    Continue Reading

  • Six dengue deaths reported, Vietnam’s Ho Chi Minh city raises outbreak alert

    Six dengue deaths reported, Vietnam’s Ho Chi Minh city raises outbreak alert